[
  {
    "ts": "2026-02-24T07:11:59+00:00",
    "headline": "FDA Accepts Regeneron (REGN) BLA for Garetosmab Under Priority Review",
    "summary": "Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the best value stocks to buy now. On February 19, Regeneron Pharmaceuticals announced that the FDA accepted its BLA for garetosmab for Priority Review. This investigational monoclonal antibody is designed to treat adults with fibrodysplasia ossificans progressiva/FOP, which is an ultra-rare and devastating genetic disorder where muscles and […]",
    "url": "https://finance.yahoo.com/news/fda-accepts-regeneron-regn-bla-071159555.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "4279ff7d-3383-3521-9fe4-b3e6997b71b1",
      "content": {
        "id": "4279ff7d-3383-3521-9fe4-b3e6997b71b1",
        "contentType": "STORY",
        "title": "FDA Accepts Regeneron (REGN) BLA for Garetosmab Under Priority Review",
        "description": "",
        "summary": "Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the best value stocks to buy now. On February 19, Regeneron Pharmaceuticals announced that the FDA accepted its BLA for garetosmab for Priority Review. This investigational monoclonal antibody is designed to treat adults with fibrodysplasia ossificans progressiva/FOP, which is an ultra-rare and devastating genetic disorder where muscles and […]",
        "pubDate": "2026-02-24T07:11:59Z",
        "displayTime": "2026-02-24T07:11:59Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/4b91a17abc1798c6665547c7b72ba5ee",
          "originalWidth": 1271,
          "originalHeight": 1280,
          "caption": "FDA Accepts Regeneron (REGN) BLA for Garetosmab Under Priority Review",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TkrNiAYKS4sSLbgJB2p6rg--~B/aD0xMjgwO3c9MTI3MTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/4b91a17abc1798c6665547c7b72ba5ee.cf.webp",
              "width": 1271,
              "height": 1280,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8w3yEMtyFUWzQ67I_iaIMw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4b91a17abc1798c6665547c7b72ba5ee.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/fda-accepts-regeneron-regn-bla-071159555.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fda-accepts-regeneron-regn-bla-071159555.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]